Ligase Enzymes Market by Type (DNA, RNA), Source (Viral, Bacterial, Eukaryotic), Grade (RUO, GMP, Diagnostic), Molecular Biology Workflow (Cloning, Sequencing, Synthetic Biology), Application (Research, Diagnostic, Therapeutic) - Global Forecast 2030

The ligase enzymes market is expected to reach USD 0.36 billion in 2030 from USD 0.26 billion in 2025, at a CAGR of 6.8% during the forecast period. The growth of the ligase enzymes market is driven by the rising adoption of genomics and next-generation sequencing (NGS), the expansion of molecular diagnostics and personalized medicine, and the increasing use of synthetic biology. Ligases play a central role in NGS workflows by enabling adapter ligation & library construction, making them indispensable in large-scale genomics projects and precision medicine initiatives. Its growing application in molecular diagnostics and precision medicine is also expected to fuel the market growth.



By grade, the GMP-grade ligase enzymes segment is projected to register the highest CAGR during the forecast period.

By grade, the ligase enzymes market is segmented into Research Use Only (RUO), GMP-grade, and diagnostic-grade ligase enzymes. The GMP-grade ligase enzymes segment is expected to grow at the highest CAGR during the forecast period. The growth is supported by the rising demand for GMP-grade ligase enzymes in therapeutic manufacturing, gene therapy, and clinical applications where compliance with stringent quality and safety standards is essential. The increasing investments in cell & gene therapies, biopharmaceutical production, and diagnostic assay development are also expected to fuel the market growth.

By source, the viral sources segment accounted for the largest share of the market in 2024.

Based on the source, the ligase enzymes market is segmented into viral, bacterial, archaeal, and eukaryotic sources. In 2024, the viral ligases segment accounted for the largest market share owing to its high adoption in applications such as molecular biology workflows, particularly in cloning, DNA repair studies, and next-generation sequencing (NGS) library preparation. Viral ligases, such as T4 DNA ligase, are considered industry standards because of their high efficiency in catalyzing the joining of DNA fragments, making them indispensable in research & industrial biotechnology.

By region, the Asia Pacific market is projected to grow at the highest CAGR during the forecast period.

By region, the market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period owing to the increasing investments in genomics research, expansion in biotechnology & pharmaceutical industries, and the rising focus on precision medicine. China, Japan, South Korea, and India are significantly scaling up their R&D capabilities through government funding, public–private partnerships, and international collaborations, creating strong demand for molecular biology tools, including ligase enzymes. The growing adoption of next-generation sequencing (NGS), synthetic biology, and molecular diagnostics for cancer, infectious diseases, and rare genetic disorders further supports market expansion.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
• By Designation: (Managers)- 45%, (CXOs, Directors)- 30%, and (Executives)- 25%
• By Region: North America- 40%, Europe- 25%, Asia Pacific- 20%, and the Rest of the World- 15%

Promega Corporation (US), New England Biolabs (UK), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), and Takara Bio Inc. (Japan) are some of the key players in the ligase enzymes market.

The study includes an in-depth competitive analysis of these key players in the ligase enzymes market and their company profiles, recent developments, and key market strategies.

Research Coverage:

This research report categorizes the ligase enzymes market by type (DNA, RNA, other ligases), by source (viral, bacterial, archaeal, eukaryotic), by grade (RUO, GMP, diagnostic), by molecular biology workflow (cloning & mutagenesis, synthetic biology, sequencing, nucleic acid amplification), by application (research, diagnostic, therapeutic development & manufacturing, other applications), by end user (academic & research institutes, pharmaceutical and biotechnology companies, hospital & diagnostic laboratories, medical device companies), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The report provides in-depth information on significant factors influencing the growth of the ligase enzymes market, including drivers, trends, challenges, and opportunities. A thorough analysis of leading industry players has been undertaken to provide insights into their business profiles, products, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches and acquisitions within the ligase enzyme market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the ligase enzyme market and its subsegments. It will also help stakeholders better understand the competitive landscape & gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

• Analysis of key drivers (rising genomics & NGS activities, growth of molecular diagnostics & personalized medicine, and increasing use in synthetic biology), restraints (dependency on research funding), opportunities (development of thermostable/performance-engineered ligases, development of lyophilized/shelf-stable ligases for point-of-care testing and low-resource markets), and challenges (batch-to-batch variability & quality control, growing adoption of ligase independent cloning) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the ligase enzyme market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ligase enzyme market
• Competitive Assessment: In-depth assessment of market share, growth strategies of leading players like New England Biolabs (UK), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), and Promega Corporation (US), among others, in the ligase enzymes market.

Show more